WuXi AppTec Co., Ltd. (HKG:2359)
62.50
-0.30 (-0.48%)
May 13, 2025, 2:45 PM HKT
WuXi AppTec Revenue
WuXi AppTec had revenue of 9.65B CNY in the quarter ending March 31, 2025, with 20.96% growth. This brings the company's revenue in the last twelve months to 39.59B, up 5.03% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
39.59B CNY
Revenue Growth
+5.03%
P/S Ratio
4.33
Revenue / Employee
1.00M CNY
Employees
39,414
Market Cap
183.60B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.26B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |